Senior Scientific Officer – Maternity Cover – Clinical PD Biomarker Group
Closing Date 04/12/2018, 23:55
Division Cancer Therapeutics
Team Clinical PD Biomarker Group
Vacancy Type Full time
Type of Contract Fixed Term
Length of Contract 1 year
Hours per Week 35
Salary: £42,368 – £50,438
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.
Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally.
The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.
The Cancer Research UK Cancer Therapeutics Unit aims to exploit the vulnerabilities of cancer cells by discovering novel and innovative small-molecule drugs for the personalised treatment of cancer. The Cancer Therapeutics Unit also develops biomarkers designed to confirm the effectiveness of molecularly targeted therapies, and help doctors to determine which therapy will benefit each patient.
The Cancer Therapeutics Unit brings together a wide variety of disciplines, including cell and molecular biology, pharmacology, tumour modelling, computational and structural biology, and medicinal chemistry, in order to select promising drug targets, design effective prototype drugs and biomarkers, and develop strategies to counter drug resistance.
A Senior Scientific Officer position is available from the beginning of December to operationally manage our Clinical PD Biomarker Group, who develop and implement pharmacodynamic biomarkers for the clinical study of a new anticancer agents. More specifically the role will involve managing staff, budgets and the clinical trial portfolio of the group, while ensuring GCP compliance. The quality control, interpretation and timely reporting of assay validation and clinical trial results is critical to the overall aim of the role to contribute to a better understanding and treatment of cancer.
Applicants should possess a BSc, MSc or PhD in molecular biology/cell biology/molecular pharmacology or a related subject and have previous experience of analytical development of assays for molecular endpoints and / or project management and scientific report writing. GCP/GCP-L training and laboratory experience is desirable.
Interviews will be held week commencing 10th December 2018
We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff.